Fact CheckerSign in

NCT06917378Recruiting

TRIO CTO (Taiwan Research Initiative on Coronary Total Occlusion)

The Multicenter Study to Evaluate Clinical and Angiographic Factors in Patients With Coronary Artery Chronic Total Occlusion in Taiwan

Source: ClinicalTrials.gov · Last updated 16 Oct 2026

Brief summary (registry, in English)

Coronary chronic total occlusions (CTO) present a significant challenge in the field of interventional cardiology. These complex lesions, characterized by complete blockage of a coronary artery for a prolonged duration, often require specialized techniques and strategies to achieve successful revascularization.

Status (registry)
Recruiting
Study type
Observational
Enrollment
5000 (estimated)
First submitted
24 Oct 2024
Start date
15 Jan 2015
Primary completion date
31 Dec 2034
Lead sponsor
National Taiwan University Hospital
NCT number
NCT06917378

What you commit to

  • Study type: Observational
  • Planned participants: 5000
  • From 15 Jan 2015 to the primary completion date, 31 Dec 2034
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

  • Over 20 years old
  • Chronic total occlusion confirmed by coronary angiography, and noted for more than 3 months

Age in the registry: 20 years to 120 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Chang Gung Memorial Hospital
Coordinator of this site? Confirm its status
New Taipei CityTaiwanRecruiting
National Taiwan University Hospital
Coordinator of this site? Confirm its status
TaipeiTaiwanRecruiting
Taipei Veterans General Hospital
Coordinator of this site? Confirm its status
TaipeiTaiwanRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.